ADVANCED-PLATELET RICH FIBRIN - A NEW ACQUISITION IN JAW OSTEONECROSIS TREATMENT
Introduction. Osteonecrosis of the jaw represents an adverse effect of a classes of drugs with both anti-osteoclastic properties and antiangiogenic properties [1], the causal association of this type of medication with osteonecrosis of the jaw was established more than a decade ago. Aim of the study...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Romanian Society of Oral Rehabilitation,
2018-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|